Mark J Enyedy - Net Worth and Insider Trading

Mark J Enyedy Net Worth

The estimated net worth of Mark J Enyedy is at least $18 Million dollars as of 2024-05-11. Mark J Enyedy is the CHIEF EXECUTIVE OFFICER of Immunogen Inc and owns about 584,397 shares of Immunogen Inc (IMGN) stock worth over $18 Million. Details can be seen in Mark J Enyedy's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark J Enyedy has not made any transactions after 2024-02-05 and currently still holds the listed stock(s).

Transaction Summary of Mark J Enyedy

To

Mark J Enyedy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark J Enyedy owns 5 companies in total, including Immunogen Inc (IMGN) , LogicBio Therapeutics Inc (LOGC) , and Akebia Therapeutics Inc (AKBA) among others .

Click here to see the complete history of Mark J Enyedy’s form 4 insider trades.

Insider Ownership Summary of Mark J Enyedy

Ticker Comapny Transaction Date Type of Owner
IMGN Immunogen Inc 2024-02-05 director & Chief Executive Officer
LOGC LogicBio Therapeutics Inc 2022-11-16 director
AKBA Akebia Therapeutics Inc 2018-12-12 director
2018-12-12 director
2013-09-30 director

Mark J Enyedy Latest Holdings Summary

Mark J Enyedy currently owns a total of 1 stock. Mark J Enyedy owns 584,397 shares of Immunogen Inc (IMGN) as of February 5, 2024, with a value of $18 Million.

Latest Holdings of Mark J Enyedy

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMGN Immunogen Inc 2024-02-05 584,397 31.23 18,250,718

Holding Weightings of Mark J Enyedy


Mark J Enyedy Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark J Enyedy has made a total of 3 transactions in Immunogen Inc (IMGN) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Immunogen Inc is the sale of 20,107 shares on February 5, 2024, which brought Mark J Enyedy around $588,733.

Insider Trading History of Mark J Enyedy

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark J Enyedy Trading Performance

GuruFocus tracks the stock performance after each of Mark J Enyedy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark J Enyedy is 31.28%. GuruFocus also compares Mark J Enyedy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark J Enyedy within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark J Enyedy's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark J Enyedy

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.59
Relative Return to S&P 500(%) 0.61

Mark J Enyedy Ownership Network

Ownership Network List of Mark J Enyedy

No Data

Ownership Network Relation of Mark J Enyedy


Mark J Enyedy Owned Company Details

What does Immunogen Inc do?

Who are the key executives at Immunogen Inc?

Mark J Enyedy is the director & Chief Executive Officer of Immunogen Inc. Other key executives at Immunogen Inc include Chief Business Officer Stacy Ann Coen , V.P.-Fin. & Prin. Acctg. Off. Renee Lentini , and VP of Regulatory Affairs Theresa Wingrove .

Immunogen Inc (IMGN) Insider Trades Summary

Over the past 18 months, Mark J Enyedy made 2 insider transaction in Immunogen Inc (IMGN) with a net sale of 3,027,661. Other recent insider transactions involving Immunogen Inc (IMGN) include a net sale of 1,058,614 shares made by Theresa Wingrove , a net sale of 301,809 shares made by Stacy Ann Coen , and a net sale of 377,001 shares made by Renee Lentini .

In summary, during the past 3 months, insiders sold 0 shares of Immunogen Inc (IMGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,785,085 shares of Immunogen Inc (IMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,785,085 shares.

Immunogen Inc (IMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunogen Inc Insider Transactions

No Available Data

Mark J Enyedy Mailing Address

Above is the net worth, insider trading, and ownership report for Mark J Enyedy. You might contact Mark J Enyedy via mailing address: C/o Fate Therapeutics, Inc., 3535 General Atomics Court, Suite 200, San Diego Ca 92121.

Discussions on Mark J Enyedy

No discussions yet.